Short Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Decreases By 36.1%

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the recipient of a significant decrease in short interest in February. As of February 28th, there was short interest totalling 2,300 shares, a decrease of 36.1% from the February 13th total of 3,600 shares. Based on an average daily trading volume, of 43,900 shares, the short-interest ratio is currently 0.1 days.

Reviva Pharmaceuticals Trading Down 5.8 %

Shares of NASDAQ RVPHW traded down $0.00 during midday trading on Friday, hitting $0.06. The stock had a trading volume of 89,456 shares, compared to its average volume of 33,273. The business’s 50 day moving average is $0.16 and its 200-day moving average is $0.16. Reviva Pharmaceuticals has a 52 week low of $0.04 and a 52 week high of $0.78.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.